Recon: AstraZeneca extends cancer drugs reach with EsoBiotec $1B purchase; Top 10 US drugs losing exclusivity this year
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States